Clinical Trial

Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 10, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load. Several comorbidities and interventions like antivirotic or antiinflammatory treatment may also modify expected patients response and decrease of viral load. In this observational study, evolution of selected inflammatory markers, indicators of severity of infection and patient characteristics will be followed and recorded in hospitalized patients with COVID-19.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-05-10; most recent amendment 2024-05-09.
Trial Details
NCT Number NCT04887623
Lead Sponsor University Hospital Hradec Kralove
Conditions COVID-19 Respiratory Infection
Enrollment 30 participants
Start Date 2021-04-01
Primary Completion 2025-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2024-05-10